Relation of MT1-MMP gene expression to outcomes in colorectal cancer

Journal of Surgical Oncology

Volumn 102, Issue 6, 2010, Pages 571-575

  Kanazawa, Amane ^a   Oshima, Takashi ^b   Yoshihara, Kazue ^b   Tamura, Shuzo ^a   Yamada, Takanobu ^a   Inagaki, Daisuke ^a   Sato, Tsutomu ^b   Yamamoto, Naoto ^a   Shiozawa, Manabu ^a   Morinaga, Soichiro ^a   Akaike, Makoto ^a   Kunisaki, Chikara ^b   Tanaka, Katsuaki ^b   Masuda, Munetaka ^c   Imada, Toshio ^c  

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

colorectal cancer; MT1 MMP; prognostic factor

Indexed keywords

MATRIX METALLOPROTEINASE 14; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER TISSUE; CLINICAL TRIAL; COLON MUCOSA; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 14; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 78349267860     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21703     Document Type: Article

References (31)

1. Weitz J, Koch M, Debus J, et al.: Colorectal cancer. Lancet 2005; 365: 153-165.
2. Kammerer R, Ehret R, von Kleist S:, Isolated extracellular matrix-based three-dimensional in vitro models to study orthotopically cancer cell infiltration and invasion. Eur J Cancer 1998; 34: 1950-1957.
3. Hornebeck W, Emonard H, Monboisse JC, et al.: Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 2002; 12: 231-241.
4. Noel A, Gilles C, Bajou K, et al.: Emerging roles for proteinases in cancer. Invasion Metastasis 1997; 17: 221-239.
5. McCawley LJ, Matrisian LM:, Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol Med Today 2000; 6: 149-156.
6. Stetler-Stevenson WG:, Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 1999; 103: 1237-1241.
7. Seiki M:, Membrane-type matrix metalloproteinases. Acta Pathol Microbiol Immunol Scand 1999; 107: 137-143.
8. Sato H, Takino T, Okada Y, et al.: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61-65.
9. Jiang A, Pei D:, Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated pro-MMP-2 activation and collagenolysis. J Biol Chem 2003; 278: 38765-38771.
10. Knauper V, Will H, Lopez-Otin C, et al.: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996; 271: 17124-17131.
11. Polette M, Nawrocki B, Gilles C, et al.: MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch 1996; 428: 29-35.
12. Weaver VM:, Membrane-associated MMP regulators: Novel cell adhesion tumor suppressor proteins ? Dev Cell 2002; 2: 6-7.
13. Takahashi C, Sheng Z, Horan TP, et al.: Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 1998; 95: 13221-13226.
14. Oshima T, Kunisaki C, Yoshihara K, et al.: Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer. Oncol Rep 2008; 19: 1285-1291.
15. Sardinha TC, Nogueras JJ, Xiong H, et al.: Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer. Dis Colon Rectum 2000; 43: 389-395.
16. Kikuchi R, Noguchi T, Takeno S, et al.: Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br J Cancer 2000; 83: 215-218.
17. Tetu B, Brisson J, Wang CS, et al.: The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis. Breast Cancer Res 2006; 8: R28.
18. Uchibori M, Nishida Y, Nagasaka T, et al.: Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol 2006; 28: 33-42.
19. Maatta M, Soini Y, Liakka A, et al.: Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: Implications for tumor progression and clinical prognosis. Clin Cancer Res 2000; 6: 2726-2734.
20. Lyall MS, Dundas SR, Curran S, et al.: Profiling markers of prognosis in colorectal cancer. Clin Cancer Res 2006; 12: 1184-1191.
21. Itoh Y, Seiki M:, MT1-MMP: A potent modifier of pericellular microenvironment. J Cell Physiol 2006; 206: 1-8.
22. Cowell S, Knauper V, Stewart ML, et al.: Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: Associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998; 331: 453-458.
23. Jadhav U, Chigurupati S, Lakka SS, et al.: Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 2004; 25: 1407-1414.
24. Folgueras AR, Pendas AM, Sanchez LM, et al.: Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int J Dev Biol 2004; 48: 411-424.
25. Atkinson JM, Pennington CJ, Martin SW, et al.: Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: Correlation of MMP-14 mRNA expression and proteolytic activity. Eur J Cancer 2007; 43: 1764-1771.
26. Figueira RC, Gomes LR, Neto JS, et al.: Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 2009; 9: 20.
27. Malhotra S, Newman E, Eisenberg D, et al.: Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: A possible mechanism of neoplastic progression. Dis Colon Rectum 2002; 45: 537-543.
28. Mimori K, Ueo H, Shirasaka C, et al.: Clinical significance of MT1-MMP mRNA expression in breast cancer. Oncol Rep 2001; 8: 401-403.
29. Zhang H, Liu M, Sun Y, et al.: MMP-14 can serve as a prognostic marker in patients with supraglottic cancer. Eur Arch Otorhinolaryngol 2009; 266: 1427-1434.
30. Yonemura Y, Endo Y, Takino T, et al.: Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer. Clin Exp Metastasis 2000; 18: 321-327.
31. Yamashita K, Tanaka Y, Mimori K, et al.: Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma. Int J Cancer 2004; 110: 201-207.